Skip to main content
Full access
Departments
Published Online: 1 April 2014

Punding as a Cause of Death in a Patient With Parkinson’s Disease

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: L-dopa and dopamine agonists are used to treat motor symptoms of Parkinson’s disease (PA), but they may also cause motor and behavioral adverse events. These are consistent with motor fluctuations, dyskinesias, anxiety disorders, psychosis, and impulse control disorders. Punding is also an impulse control disorder, and here we present a 71-year-old patient with PA who died from secondary complications because of punding.

Case Report

A 71-year-old man with idiopathic PD was on L-dopa, pramipexole, amantadine, and rasagiline treatment for 10 years. He also had diabetes mellitus and hypertension but no history of alcohol or drug abuse. His daughter complained about his excessive fixing of furniture (sofa bed) and electronic devices (television and radios). The recommended treatment dose was 3 mg/day, but he had started using larger doses up to 12 mg/day of pramipexole and 750 mg/day of L-dopa with developing peak-dose dyskinesias and motor fluctuations for 3 years, and he stopped taking amantadine treatment. He said that he could not stop fixing objects because of his irresistible desire to repair them. He was diagnosed with impulse control disorder (ICD) and after stopping amantadine, his ICD was worse. Quetiapine 25 mg/day dose was given and increased to 400 mg/day, and pramipexole dose was gradually decreased to treat punding behaviors. However, there was no improvement with these treatments and punding behaviors continued. Two months later, his daughter found him trapped under a closed sofa bed in an unconscious state for 8 hours, resulting from head and neck trauma that he sustained while fixing the sofa bed. He was admitted to neurosurgery service, but he died from secondary complications after 2 weeks.
Impulse control disorders (ICD) are characterized by excessive shopping, pathologic gambling, hypersexuality, compulsive eating, and compulsive dopaminergic drug usage.1 These are important behaviors because they can cause personal, financial, and familial consequences.2 Punding is also a ICD, and it is a stereotypical motor behavior in which there is an intense fascination with repetitive handling and examining of mechanical objects, such as picking at oneself or taking apart watches and radios or sorting and arranging of common objects, such as lining up pebbles, rocks, or other small objects.3 Punding was a cause of death in our patient with PD.
It is known that decreasing dopamine exposure is an effective way to manage ICD that occurs during dopamine treatment. In one case report, a patient with PD presenting disabling punding was reversed by amantadine without aggravating motor function.4 Also, our patient’s punding behaviors had increased after stopping amantadine. In a study, it had been suggested that neural systems mediating the expression of dyskinesias and punding might overlap, and punding should sought systematically in PD patients presenting with disabling severe dyskinesias.5 We report this case because aside from personal, financial, and familial consequences, ICD and punding may sometimes cause death. This should be kept in mind in PD.

References

1.
Voon V, Sohr M, Lang AE, et al.: Impulse control disorders in Parkinson disease: a multicenter case—control study. Ann Neurol 2011; 69:986–996
2.
Ceravolo R, Frosini D, Rossi C, et al.: Impulse control disorders in Parkinson’s disease: definition, epidemiology, risk factors, neurobiology and management. Parkinsonism Relat Disord 2009; 15(Suppl 4):S111–S115
3.
Fernandez HH, Friedman JH: Punding on L-dopa. Mov Disord 1999; 14:836–838
4.
Kashihara K, Imamura T. Amantadine may reverse punding in Parkinson’s disease—observation in a patient. Mov Disord 2008; 23:129–130
5.
Silveira-Moriyama L, Evans AH, Katzenschlager R, Lees AJ. Punding and dyskinesias. Mov Disord 2006; 21:2214–2217

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E15
PubMed: 24763773

History

Published online: 1 April 2014
Published in print: Spring 2014

Authors

Details

Ayhan Köksal, M.D.
Dept. of Neurology, Bakirkoy Training and Research Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey
Neslihan Hatice Sütpideler Köksal, M.D.
Dept. of Neurosurgery, Samatya Training and Research Hospital, Istanbul, Turkey

Notes

Send correspondence to Dr. Köksal; e-mail:[email protected]

Competing Interests

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share